Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Afatinib vs Cetuximab in Metastatic Colorectal Cancer
NCT01152437Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jun 2010
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of afatinib in colorectal cancer (CRC), sponsored by Boehringer Ingelheim. Started Jun 2010; status: completed.
02
Drugs
afatinib
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01152437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01152437.